Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Ascelia Pharma AB (publ) per 2025 Jun 30 adalah -83.17 MM.
- Nilai net income untuk Ascelia Pharma AB (publ) per 2025 Jun 30 adalah -94.78 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -83.17 | -94.78 | |
2025-03-31 | -71.38 | -85.07 | |
2024-12-31 | -68.12 | -80.03 | |
2024-09-30 | -57.45 | -62.30 | |
2024-06-30 | -60.66 | -61.78 | |
2024-03-31 | -91.54 | -88.76 | |
2023-12-31 | -111.47 | -109.29 | |
2023-09-30 | -152.69 | -152.07 | |
2023-06-30 | -161.68 | -156.81 | |
2023-03-31 | -151.98 | -139.37 | |
2022-12-31 | -147.67 | -131.22 | |
2022-09-30 | -133.95 | -112.91 | |
2022-06-30 | -137.07 | -115.48 | |
2022-03-31 | -136.86 | -126.16 | |
2021-12-31 | -137.90 | -125.90 | |
2021-09-30 | -126.50 | -126.68 | |
2021-06-30 | -110.05 | -112.85 | |
2021-03-31 | -106.34 | -110.80 | |
2020-12-31 | -93.26 | -98.70 | |
2020-09-30 | -88.41 | -89.98 | |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | -1.48 | |
2024-09-30 | -1.63 | -1.63 |
2024-06-30 | -1.83 | -1.83 |
2024-03-31 | -2.63 | -2.63 |
2023-12-31 | -3.24 | |
2023-09-30 | -4.45 | -4.45 |
2023-06-30 | -4.50 | -4.50 |
2023-03-31 | -4.03 | -4.03 |
2022-12-31 | -3.77 | |
2022-09-30 | -3.27 | -3.27 |
2022-06-30 | -3.36 | -3.36 |
2022-03-31 | -3.67 | -3.67 |
2021-12-31 | -3.82 | |
2021-09-30 | -4.02 | -4.02 |
2021-06-30 | -3.79 | -3.79 |
2021-03-31 | -4.02 | -4.02 |
2020-12-31 | -3.76 | |
2020-09-30 | -3.61 | -3.61 |
2020-06-30 | -3.73 | -3.73 |
2020-03-31 | -3.03 | -3.03 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Ascelia Pharma AB (publ) per 2025 Jun 30 adalah -70.73 MM.
- Nilai cash from investing activities untuk Ascelia Pharma AB (publ) per 2025 Jun 30 adalah -0.06 MM.
- Nilai kas dari aktivitas pendanaan untuk Ascelia Pharma AB (publ) per 2025 Jun 30 adalah 102.28 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -70.73 | -0.06 | 102.28 |
2025-03-31 | -64.71 | 96.04 | |
2024-12-31 | -62.84 | 115.19 | |
2024-09-30 | -59.99 | 0.00 | 116.94 |
2024-06-30 | -73.97 | 0.05 | 33.56 |
2024-03-31 | -104.31 | 0.05 | 18.21 |
2023-12-31 | -126.79 | 0.05 | -0.94 |
2023-09-30 | -139.58 | 0.05 | -0.95 |
2023-06-30 | -141.04 | -0.00 | -0.97 |
2023-03-31 | -131.43 | -0.00 | -0.99 |
2022-12-31 | -125.26 | -0.07 | -1.10 |
2022-09-30 | -128.79 | -0.07 | -1.13 |
2022-06-30 | -127.03 | -0.06 | -1.16 |
2022-03-31 | -124.98 | -0.10 | 185.31 |
2021-12-31 | -116.56 | -0.04 | 184.87 |
2021-09-30 | -111.87 | 69.35 | 184.97 |
2021-06-30 | -100.02 | 69.35 | 278.43 |
2021-03-31 | -90.12 | 70.32 | 92.05 |
2020-12-31 | -85.53 | 75.99 | 92.72 |
2020-09-30 | -74.76 | 6.60 | 92.87 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Ascelia Pharma AB (publ) pada 2025 Jun 30 adalah -4.93.
- p/libro untuk Ascelia Pharma AB (publ) pada 2025 Jun 30 adalah 7.26.
- p/tbv untuk Ascelia Pharma AB (publ) pada 2025 Jun 30 adalah 559.34.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -4.93 | 7.26 | 559.34 |
2025-03-31 | -3.50 | 3.55 | 12.81 |
2024-12-31 | -4.67 | 2.71 | 5.77 |
2024-09-30 | -3.49 | 4.52 | -22.97 |
2024-06-30 | -3.31 | 4.67 | 50.61 |
2024-03-31 | -1.31 | 1.92 | 8.27 |
2023-12-31 | -0.94 | 1.69 | 5.19 |
2023-09-30 | -0.91 | 1.35 | 2.94 |
2023-06-30 | -1.98 | 2.95 | 6.41 |
2023-03-31 | -2.23 | 2.15 | 3.55 |
2022-12-31 | -1.26 | 0.62 | 0.82 |
2022-09-30 | -2.75 | 1.35 | 1.79 |
2022-06-30 | -2.69 | 1.21 | 1.55 |
2022-03-31 | -2.46 | 1.11 | 1.39 |
2021-12-31 | -1.15 | 0.43 | 0.51 |
2021-09-30 | -2.45 | 0.91 | 1.09 |
2021-06-30 | -2.75 | 0.84 | 1.00 |
2021-03-31 | -2.38 | 0.66 | 0.77 |
2020-12-31 | -1.33 | 0.44 | 0.56 |
2020-09-30 | -2.89 | 0.96 | 1.22 |
2020-06-30 | -2.55 | 0.92 | 1.15 |
2020-03-31 | -2.55 | 0.98 | 1.32 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Ascelia Pharma AB (publ) pada 2025 Jun 30 adalah -0.22.
- EBIT (3 tahun) / EV untuk Ascelia Pharma AB (publ) pada 2025 Jun 30 adalah -0.26.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.22 | -0.26 |
2025-03-31 | -0.31 | -0.40 |
2024-12-31 | -0.28 | -0.50 |
2024-09-30 | -0.28 | -0.50 |
2024-06-30 | -0.31 | -0.42 |
2024-03-31 | -0.91 | -1.03 |
2023-12-31 | -1.47 | -1.28 |
2023-09-30 | -2.18 | -1.81 |
2023-06-30 | -0.65 | -0.54 |
2023-03-31 | -0.70 | -0.64 |
2022-12-31 | 3.10 | 3.00 |
2022-09-30 | -0.89 | -0.86 |
2022-06-30 | -1.18 | -1.10 |
2022-03-31 | -1.67 | -1.40 |
2021-12-31 | 0.89 | 0.61 |
2021-09-30 | -6.56 | -4.51 |
2021-06-30 | 13.86 | 10.28 |
2021-03-31 | -1.14 | -0.77 |
2020-12-31 | 2.82 | 1.65 |
2020-09-30 | -0.84 | -0.49 |
2020-06-30 | -0.56 | -0.30 |
2020-03-31 | -0.75 | -0.34 |
Efektivitas Manajemen
- roa untuk Ascelia Pharma AB (publ) pada 2025 Jun 30 adalah -0.90.
- roe untuk Ascelia Pharma AB (publ) pada 2025 Jun 30 adalah -1.78.
- roic untuk Ascelia Pharma AB (publ) pada 2025 Jun 30 adalah -1.00.
- croic untuk Ascelia Pharma AB (publ) pada 2025 Jun 30 adalah 0.36.
- ocroic untuk Ascelia Pharma AB (publ) pada 2025 Jun 30 adalah -0.76.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.90 | -1.78 | -1.00 | 0.36 | -0.76 |
2025-03-31 | -0.87 | -1.35 | -0.61 | 0.41 | -0.48 |
2024-12-31 | -0.59 | -0.74 | -0.46 | 0.42 | -0.45 |
2024-09-30 | -0.59 | -0.74 | -0.76 | -0.50 | -0.90 |
2024-06-30 | -0.49 | -0.61 | -1.09 | -1.04 | -1.28 |
2024-03-31 | -0.50 | -0.60 | -1.45 | -1.69 | -1.68 |
2023-12-31 | -0.60 | -0.66 | -1.77 | -1.64 | -1.63 |
2023-09-30 | -0.55 | -0.61 | -1.46 | -1.29 | -1.32 |
2023-06-30 | -0.49 | -0.61 | -1.46 | -1.29 | -1.32 |
2023-03-31 | -0.43 | -0.50 | -0.95 | -0.83 | -0.90 |
2022-12-31 | -0.31 | -0.33 | -0.49 | -0.48 | -0.56 |
2022-09-30 | -0.32 | -0.33 | -0.49 | -0.48 | -0.56 |
2022-06-30 | -0.32 | -0.31 | -0.45 | -0.43 | -0.49 |
2022-03-31 | -0.29 | -0.32 | -0.45 | 0.24 | -0.44 |
2021-12-31 | -0.44 | -0.47 | -0.37 | 0.41 | -0.33 |
2021-09-30 | -0.44 | -0.47 | -0.37 | 0.41 | -0.27 |
2021-06-30 | -0.36 | -0.40 | -0.30 | 0.65 | -0.27 |
2021-03-31 | -0.47 | -0.50 | -0.28 | 0.16 | -0.22 |
2020-12-31 | -0.33 | -0.34 | -0.33 | 0.08 | -0.28 |
2020-09-30 | -0.33 | -0.34 | -0.33 | 0.08 | -0.28 |
2020-06-30 | -0.35 | -0.37 | -0.36 | -0.26 | -0.27 |
2020-03-31 | -0.30 | -0.31 | -0.38 | -1.19 | -0.40 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |